the aid library

LIST OPTIONS

Filter

4706

Sort by:

Direction:

Download (83)

View PDF (129)

Guidelines for the use of non-pharmaceutical measures to delay and mitigate the impact of 2019-nCoV

European Centre for Disease Prevention and Control ECDC (2020) C1

This document provides guidance on the application of non-pharmaceutical countermeasures to minimise the spread of the 2019 novel coronavirus (2019-nCoV) in the population. Some of the measures proposed refer specifically to certain phases of the epidemic (containment or mitigation phases), and can ... more

Download (76)

View PDF (111)

Advisory for quarantine of migrant workers

Ministery of Health and Family Welfare - Government of India (2020) C2

Coronavirus disease 2019 (COVID-19) is an acute infectious respiratory disease caused by a newly discovered coronavirus (SARS-CoV-2). Most people infected with the COVID-19 virus experience mild to moderate respiratory illness and recover without requiring special treatment, the disease presentati... more

Download (80)

View PDF (133)

Preliminary Stakeholder Engagement Plan (SEP)

India COVID-19 Emergency Response and Health Systems Preparedness Project (P173836) Ministery of Health and Familiy Welfare - Government of India (2020) C2

A new respiratory infectious disease, COVID-19, caused by a new coronavirus called SARS-CoV-2, emerged in early December 2019. Since then, the virus has spread to India and 106 other countries in Asia, Europe, North America, Africa, and Oceania. On March 11, the World Health Organization (WHO) decl... more

Download (70)

View PDF (111)

Action Protocol for Enhanced SARI and ILI Surveillance for COVID-19 in Africa (Arabic)

African Union; Africa CDC Centres for Disease Control and Prevention (2020) C2

March 2020 The number of African Union Member States reporting COVID- 19 cases is increasing and there is a likelihood of community transmission. The WHO recently modified the COVID-19 suspect case definition to include severe acute respiratory infection and advises testing of all severe acute r... more

Download (60)

View PDF (119)

Declaração de Posição sobre a Transmissão de SARS-CoV-2

African Union; Africa CDC Centres for Disease Control and Prevention (2020) C1

Nas últimas semanas, tem havido uma ampla atenção dos meios de comunicação social sobre o risco de transmissão do novo coronavírus [síndrome respiratório agudo grave coronavírus 2 (SRA-CoV-2)] por indivíduos assintomáticos. Esta situação também tem sido amplamente discutida em várias... more

Download (97)

View PDF (144)

Guidance on Setting Up an Isolation Ward for COVID-19 Cases (Arabic Version)
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2020) C1

إرشاداتٌ حول إنشاء عنابر العزل الخاصة بالحالات المصابة بفيروس كورونا المستجد This document simplifies the WHO guidance on severe acute respiratory infection (SARI) treatment centres and is meant to be accessible to healthcare work... more

Download (66)

View PDF (108)

Heating, ventilation and air-conditioning systems in the context of COVID-19: first update

European Centre for Disease Prevention and Control ECDC (2020) C1

The first update of the ECDC ventilation guidance document contains: key new findings that emphasise four bundles of NPIs to reduce the risk of SARS-CoV-2 transmission in closed spaces; updated references on the evidence of transmission in closed spaces; recommendations based on the n... more

Download (80)

View PDF (104)

Interim Guidance on the Use of Rapid Antigen tests for COVID-19 Response
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2020) C1

16 Dec. 2020 This document provides guidance to Ministries of Health (MOHs), laboratory personnel and implementing partners in African Union Member States on the application of rapid antigen tests to COVID-19 testing. The guidance serves as reference for policymakers, laboratory leads, implementing... more

Download (107)

View PDF (153)

The Use of Pulse Oximeter by Public & Healthcare Providers in the Community for Suspected and Confirmed COVID-19 Cases
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2021) CC

27 May 2021 This is a document to support the use of pulse oximeter for assessment of suspected and confirmed cases of Covid-19 in the community. It is a well-known fact that Covid-19 can present as “happy hypoxia” with minimum symptoms of severe respiratory distress despite significant low ox... more

Download (104)

View PDF (150)

La Tuberculosis es curable

Ministerio de Salud, El Salvador (2021) CC

Website with information about TB and Respiratory diseases

Download (149)

View PDF (165)

Revised COVID-19 Testing Strategy
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2022) CC

Second edition. June 2022. This revised guidance recommends that access to COVID-19 testing is decentralized as far as possible and made available at health facilities, and through the use of self tests to enable access to care and the mitigation of transmission. Testing should be prioritized for hi... more

Download (27)

View PDF (13)

International Pharmaceutical Federation (FIP) - A handbook for pharmacists

Nunes da Cunha I., Autry E. et al International Pharmaceutical Federation (FIP) (2022) CC2

The document "Chronic Respiratory Diseases: A Handbook for Pharmacists" outlines the significant role pharmacists play in managing asthma and COPD, emphasizing patient education, disease prevention, medication management, and promoting healthy lifestyles. It highlights the importance of pharmacists ... more

Download (16)

View PDF (16)

Challenges in the diagnosis of asthma in children, what are the solutions? A scoping review of 3 countries in sub Saharan Africa 2022

Magwenzi, P.; Rusakaniko, S.; Sibanda, E.N.; Gumbo, F.Z. (2022) CC2

Asthma is the commonest chronic respiratory tract disease in children. In low-income countries, challenges exist in asthma diagnosis. In surveys done in children, the prevalence of ‘asthma’ defined by symptoms is high compared to ‘doctor diagnosed asthma’. The questions answered by this revi... more

Download (18)

View PDF (13)

Assessing the nature of asthma in African epidemiological studies: a scoping review protocol

Ndlovu, V.; Chimbari, M.J.; Sibanda, E. (2020) CC2

Asthma is one of the most common chronic respiratory conditions in the world and is increasing in prevalence, particularly in Africa and other low-income countries. The disproportionately high numbers of premature deaths and severe or uncontrolled cases in many African countries are indicative of th... more

Download (36)

View PDF (19)

Assessing the nature of asthma in African epidemiological studies: a scoping review protocol 2020

Ndlovu, V.; Chimbari, M.J.; Sibanda, E. (2020) CC2

Download (36)

View PDF (26)

An estimate of asthma prevalence in Africa: a systematic analysis

Adeloye, D.; Chan, K. Y.; Rudan, I.; Campell, H. National Library of Medicine (2013) CC2

Chronic respiratory diseases (CRDs) are among the leading causes of death worldwide, with asthma rated the most common chronic disease affecting children (1). Globally, about 300 million people have asthma, and current trends suggest that an additional 100 million people may be living with asthma by... more

Download (29)

View PDF (11)

Prevalence of asthma in North Africa: the Asthma Insights and Reality in the Maghreb (AIRMAG) study

Nafti, S.; Taright, S.; El Ftouh, M.; et al. (2009) CC2

Bronchial asthma is the most frequent chronic respiratory disease in both adults and children. The prevalence and burden of asthma vary considerably between different regions of the world. Information on asthma in Africa is fragmentary and relatively old.

Download (23)

View PDF (19)

Understanding and controlling asthma in Latin America: A review of recent research informed by the SCAALA programme

Cooper, P. J.; Figueiredo, C. A.; Rodriguez, A.; et al. (2023) CC2

Asthma is the most common chronic respiratory disease (CRD) worldwide and is estimated to affect 262 million causing significant mortality and morbidity, and has emerged as an important public health problem in many Latin American (LA) countries over the last 30 or so years. LA is a highly diverse r... more

Download (31)

View PDF (23)

Vigilância global, prevenção e controlo das doenças respiratórias crónicas: uma abordagem integradora

Bousquet, J.; Khaltaev, N. (2007) C_WHO

Chronic respiratory diseases, such as asthma and chronic obstructive pulmonary disease, kill more than four million people every year and affect hundreds of millions more. These diseases erode the health and well-being of the patients and have a negative impact on families and societies. Women ... more

Download (3)

View PDF (2)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Guidance on Setting Up an Isolation Ward for COVID-19 Cases (Arabic Version) recommended

Interim Guidance on the Use of Rapid Antigen tests for COVID-19 Response recommended

The Use of Pulse Oximeter by Public & Healthcare Providers in the Community for Suspected and Confirmed COVID-19 Cases recommended

Revised COVID-19 Testing Strategy recommended

Guidance on Setting Up an Isolation Ward for COVID-19 Cases (Arabic Version)
recommended

Interim Guidance on the Use of Rapid Antigen tests for COVID-19 Response
recommended

The Use of Pulse Oximeter by Public & Healthcare Providers in the Community for Suspected and Confirmed COVID-19 Cases
recommended

Revised COVID-19 Testing Strategy
recommended